• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of Helicobacter pylori infection: the past and the future.

作者信息

Gisbert Javier P, Pajares José María

机构信息

Department of Gastroenterology, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Playa de Mojácar 29, Madrid, Spain.

出版信息

Eur J Intern Med. 2010 Oct;21(5):357-9. doi: 10.1016/j.ejim.2010.07.009. Epub 2010 Aug 1.

DOI:10.1016/j.ejim.2010.07.009
PMID:20816583
Abstract
摘要

相似文献

1
Treatment of Helicobacter pylori infection: the past and the future.幽门螺杆菌感染的治疗：过去与未来。
Eur J Intern Med. 2010 Oct;21(5):357-9. doi: 10.1016/j.ejim.2010.07.009. Epub 2010 Aug 1.
2
Levofloxacin in first-line treatment of Helicobacter pylori infection.
Helicobacter. 2007 Aug;12(4):364-5. doi: 10.1111/j.1523-5378.2007.00517.x.
3
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.以左氧氟沙星为基础和以克拉霉素为基础的三联疗法作为一线和二线治疗幽门螺杆菌感染：一项随机对照交叉试验。
Gut. 2010 May;59(5):572-8. doi: 10.1136/gut.2009.198309.
4
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.左氧氟沙星、克拉霉素和埃索美拉唑三联疗法作为中东地区幽门螺杆菌根除的一线治疗的疗效和安全性：前瞻性、随机、盲法、对照、多中心研究。
Eur J Intern Med. 2010 Aug;21(4):310-4. doi: 10.1016/j.ejim.2010.05.011. Epub 2010 Jun 16.
5
On the efficacy of macrolide-based therapy for Helicobacter pylori infection.
Panminerva Med. 2009 Mar;51(1):51; author reply 51-2.
6
Efficacy of clarithromycin in eradicating Helicobacter pylori.克拉霉素根除幽门螺杆菌的疗效。
J Gastroenterol. 1996 Nov;31 Suppl 9:53-5.
7
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.含左氧氟沙星的三联疗法用于根除传统三联疗法失败后的持续性幽门螺杆菌。
Helicobacter. 2007 Aug;12(4):359-63. doi: 10.1111/j.1523-5378.2007.00507.x.
8
Clarithromycin for treatment of Helicobacter pylori infections.克拉霉素用于治疗幽门螺杆菌感染。
Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S55-8.
9
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.临床试验：克拉霉素对比左氧氟沙星一线三联及序贯疗法根除幽门螺杆菌。
Aliment Pharmacol Ther. 2010 May;31(10):1077-84. doi: 10.1111/j.1365-2036.2010.04274.x. Epub 2010 Feb 20.
10
The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.甲硝唑耐药水平对幽门螺杆菌根除成功的重要性。
Aliment Pharmacol Ther. 2004 Jun 15;19(12):1315-21. doi: 10.1111/j.1365-2036.2004.01959.x.

引用本文的文献

1
A Comprehensive Review of Xanthan Gum-Based Oral Drug Delivery Systems.基于黄原胶的口服药物传递系统的全面综述。
Int J Mol Sci. 2024 Sep 21;25(18):10143. doi: 10.3390/ijms251810143.
2
A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against .基于生物发光的药物筛选确定了非昔硝唑及其代谢物对……的活性 。 （原文结尾不完整，翻译可能存在一定局限性）
Antibiotics (Basel). 2022 Nov 11;11(11):1605. doi: 10.3390/antibiotics11111605.
3
Efficacy of levofloxacin, omeprazole, nitazoxanide, and doxycycline (LOAD) regimen compared with standard triple therapy to eradicate infection: a prospective randomized study from a tertiary hospital in India.
左氧氟沙星、奥美拉唑、硝唑尼特和强力霉素（LOAD）方案与标准三联疗法根除感染的疗效比较：一项来自印度一家三级医院的前瞻性随机研究。
Gastroenterol Hepatol Bed Bench. 2021 Fall;14(4):342-348.
4
Safety and Efficacy of Nitazoxanide-Based Regimen for the Eradication of Infection: A Systematic Review and Meta-Analysis.基于硝唑尼特的感染根除方案的安全性和有效性：一项系统评价与荟萃分析
Gastroenterology Res. 2020 Dec;13(6):260-268. doi: 10.14740/gr1342. Epub 2020 Dec 23.
5
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.含铋剂的一线四联疗法联合左氧氟沙星或克拉霉素根除幽门螺杆菌感染的疗效：一项为期1周的开放标签随机试验。
Medicine (Baltimore). 2017 Feb;96(7):e5859. doi: 10.1097/MD.0000000000005859.
6
Effect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori.天然胃黏液对针对幽门螺杆菌的体内杂交疗法的影响。
Mol Ther Nucleic Acids. 2015 Dec 8;4(12):e269. doi: 10.1038/mtna.2015.46.
7
Production of specific IgY Helicobacter pylori recombinant OipA protein and assessment of its inhibitory effects towards attachment of H. pylori to AGS cell line.特异性抗幽门螺杆菌重组OipA蛋白IgY的制备及其对幽门螺杆菌黏附AGS细胞系抑制作用的评估
Clin Exp Vaccine Res. 2015 Jul;4(2):177-83. doi: 10.7774/cevr.2015.4.2.177. Epub 2015 Jul 29.
8
Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.用于根除幽门螺杆菌的胃滞留型左氧氟沙星漂浮微丸胶囊系统的设计与评价
Saudi Pharm J. 2014 Dec;22(6):570-9. doi: 10.1016/j.jsps.2014.02.009. Epub 2014 Mar 6.
9
Anti-Helicobacter pylori activity and Structure-Activity Relationship study of 2-Alkylthio-5-(nitroaryl)-1,3,4-thiadiazole Derivatives.2-烷硫基-5-（硝基芳基）-1,3,4-噻二唑衍生物的抗幽门螺杆菌活性及构效关系研究
Iran J Pharm Res. 2013 Summer;12(3):281-7.
10
NMR study on small proteins from Helicobacter pylori for antibiotic target discovery: a review.NMR 研究幽门螺杆菌中小蛋白作为抗生素靶标发现：综述。
Molecules. 2013 Oct 30;18(11):13410-24. doi: 10.3390/molecules181113410.